Puma Biotechnology Presents Efficacy and Safety Outcomes from the Phase III NALA Trial at the 2020 SABCS

December 11, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Puma Biotechnology Presents Efficacy and Safety Outcomes from the Phase III NALA Trial at the 2020 SABCS

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology presented efficacy and safety outcomes from the Phase III NALA Trial in a Spotlight Poster at the 2020 Virtual SABCS.